Literature DB >> 2420889

Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.

T Kinoshita, M E Medof, V Nussenzweig.   

Abstract

Decay-accelerating factor (DAF) is a membrane glycoprotein found on various cells that are in contact with complement. It inhibits the formation of the C3 convertases of the complement system, both the classic (C4b2a) and alternative (C3bBb) pathways. In this investigation, we used a homobifunctional cross-linking reagent to search for a DAF ligand on the surface of cells subjected to complement attack. We found that DAF forms complexes with C4b and C3b deposited on the same erythrocytes, but not with the physiologic degradation products of these complement fragments, that is, C4d or C3dg. Taken together with prior observations that DAF action is reversible, and DAF does not affect the structure of C4b or C3b, these findings suggest that DAF functions by competitively inhibiting the uptake of C2 or factor B, and preventing the assembly of the C3 convertases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420889

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Adenovirus type 11 uses CD46 as a cellular receptor.

Authors:  Anna Segerman; John P Atkinson; Marko Marttila; Veronica Dennerquist; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.

Authors:  J G Wilson; N A Andriopoulos; D T Fearon
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 3.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.

Authors:  M G Wing; J Zajicek; D J Seilly; D A Compston; P J Lachmann
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

6.  Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi.

Authors:  K A Norris; J E Schrimpf
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

7.  C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3.

Authors:  A Eigentler; T F Schulz; C Larcher; E M Breitwieser; B L Myones; A L Petzer; M P Dierich
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.

Authors:  Pallop Karnchanaphanurach; Rossen Mirchev; Ionita Ghiran; John M Asara; Brigitte Papahadjopoulos-Sternberg; Anne Nicholson-Weller; David E Golan
Journal:  J Clin Invest       Date:  2009-03-02       Impact factor: 14.808

9.  Analysis of the signal for attachment of a glycophospholipid membrane anchor.

Authors:  I W Caras; G N Weddell; S R Williams
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

10.  Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.

Authors:  C N Metz; G Brunner; N H Choi-Muira; H Nguyen; J Gabrilove; I W Caras; N Altszuler; D B Rifkin; E L Wilson; M A Davitz
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.